Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Squamous Intraepithelial Lesions 1Skin Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 7Nivolumab 3atezolizumab 2Aminolevulinic Acid 2testosterone enanthate 1regorafenib 1osimertinib 1nanocis 1fluoroazomycin arabinoside 1fludarabine 1cobimetinib 1cabozantinib 1avelumab 1aldesleukin 1aflibercept 1Vorinostat 1Therapeutics 1Technetium-99 1Solutions 1Red Light 1Radiation, Ionizing 1Proton Pump Inhibitors 1Paclitaxel 1Observation 1NEO212 1Metformin 1Ipilimumab 1Interleukin-2 1Infracyanine green 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Blue Light × Gynecologic × Clear all
NCT06159842 2025-02-12

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

The Center for Clinical and Cosmetic Research

Phase 2 Completed
32 enrolled
DermatologicGynecologic

Squamous Intraepithelial Lesions, Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡